An arm of the European Medicines Agency (EMA) has recommended expanding the European approval of Johnson & Johnson‘s Tecvayli (teclistamab) to treat adults with…

I sit in the waiting room with a half-read magazine on my lap and realize that I haven’t turned a single page. The clock on…

The experimental immunotherapy IGV-001 may improve survival outcomes in certain people with an aggressive form of glioma called glioblastoma (GBM), according to a new…